Prospera Private Wealth LLC Makes New Investment in Danaher Co. (NYSE:DHR)

Prospera Private Wealth LLC purchased a new position in shares of Danaher Co. (NYSE:DHR - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 13,514 shares of the conglomerate's stock, valued at approximately $3,757,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Avior Wealth Management LLC grew its holdings in shares of Danaher by 17.1% during the third quarter. Avior Wealth Management LLC now owns 15,750 shares of the conglomerate's stock worth $4,379,000 after buying an additional 2,305 shares in the last quarter. West Family Investments Inc. boosted its position in Danaher by 17.3% during the third quarter. West Family Investments Inc. now owns 1,692 shares of the conglomerate's stock worth $470,000 after acquiring an additional 249 shares during the last quarter. Second Half Financial Partners LLC purchased a new stake in Danaher during the 3rd quarter valued at about $351,000. PNC Financial Services Group Inc. raised its holdings in Danaher by 0.5% in the 3rd quarter. PNC Financial Services Group Inc. now owns 303,043 shares of the conglomerate's stock valued at $84,252,000 after acquiring an additional 1,499 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of Danaher during the 3rd quarter worth approximately $77,314,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company's stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 10.90% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on DHR shares. Royal Bank of Canada cut their price target on Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. TD Cowen raised their target price on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research note on Wednesday, October 23rd. Raymond James lowered their price target on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 23rd. Finally, StockNews.com lowered shares of Danaher from a "buy" rating to a "hold" rating in a report on Monday. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $287.16.

Danaher Stock Up 0.6 %

Danaher stock traded up $1.29 during mid-day trading on Wednesday, reaching $232.13. 1,158,089 shares of the company's stock were exchanged, compared to its average volume of 2,757,522. The company has a fifty day moving average of $260.45 and a 200-day moving average of $260.32. The company has a market cap of $167.66 billion, a P/E ratio of 44.04, a P/E/G ratio of 4.24 and a beta of 0.85. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a twelve month low of $213.61 and a twelve month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company's revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the company earned $2.02 EPS. Sell-side analysts expect that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.47%. The ex-dividend date of this dividend was Friday, September 27th. Danaher's payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.